How is Epi proColon used to screen for colon cancer?

Updated: Apr 15, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

In 2016, the FDA approved the first blood-based colorectal cancer screening test, Epi proColon. This is a qualitative in vitro assay for detecting methylated Septin9 DNA, which has been associated with the occurrence of colorectal cancer, in plasma obtained from whole-blood specimens. It is indicated for use in average-risk patients who have chosen not to undergo other screening methods, such as colonoscopy or stool-based tests. [59]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!